Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Roberta Ambrosio"'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 1, Pp 33-38 (2008)
Antonio Gambardella1,2, Angelo Labate1,2, Eleonora Colosimo1, Roberta Ambrosio1, Aldo Quattrone1,21Institute of Neurology, University Magna Græcia, Catanzaro, Italy; 2Institute of Neurological Sciences, National Research Council, Piano Lago di Mango
Externí odkaz:
https://doaj.org/article/1a7df4e371224d898411412d571ef248
Autor:
Christiana Graf, Roberta D’Ambrosio, Elisabetta Degasperi, Stefania Paolucci, Jordi Llaneras, Johannes Vermehren, Georg Dultz, Kai-Henrik Peiffer, Fabian Finkelmeier, Eva Herrmann, Stefan Zeuzem, Maria Buti, Pietro Lampertico, Julia Dietz, Christoph Sarrazin
Publikováno v:
JHEP Reports, Vol 6, Iss 3, Pp 100994- (2024)
Background & Aims: Voxilaprevir/velpatasvir/sofosbuvir (VOX/VEL/SOF) is highly effective for re-treatment of direct-acting antiviral (DAA)-experienced patients with chronic HCV infection. In the present study, predictors of virologic treatment respon
Externí odkaz:
https://doaj.org/article/19457f73f2454109b2631336ff2f0579
Autor:
Laura Micheli, Alessandra Pacini, Lorenzo Di Cesare Mannelli, Elena Trallori, Roberta D’Ambrosio, Carlo Bianchini, Pietro Lampertico, Carla Ghelardini
Publikováno v:
Nutrients, Vol 16, Iss 13, p 2130 (2024)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/a3769eb50377457ca45d60d7967164bf
Autor:
Maria Giovanna Quaranta, Luisa Cavalletto, Francesco Paolo Russo, Vincenza Calvaruso, Luigina Ferrigno, Alberto Zanetto, Benedetta Mattioli, Roberta D’Ambrosio, Valentina Panetta, Giuseppina Brancaccio, Giovanni Raimondo, Maurizia Rossana Brunetto, Anna Linda Zignego, Carmine Coppola, Andrea Iannone, Elisa Biliotti, Elena Rosselli Del Turco, Marco Massari, Anna Licata, Francesco Barbaro, Marcello Persico, Filomena Morisco, Maurizio Pompili, Federica Cerini, Massimo Puoti, Teresa Santantonio, Antonio Craxì, Loreta A. Kondili, Liliana Chemello, on behalf of PITER Collaborating Investigators
Publikováno v:
Viruses, Vol 16, Iss 5, p 682 (2024)
The treatment of hepatitis C virus (HCV) with direct-acting antivirals (DAA) leads to high sustained virological response (SVR) rates, but hepatocellular carcinoma (HCC) risk persists in people with advanced liver disease even after SVR. We weighted
Externí odkaz:
https://doaj.org/article/0a099c6b55904c89a7f8b467d025b283
Autor:
Alessio Aghemo, Marcello Persico, Roberta D'Ambrosio, Massimo Andreoni, Erica Villa, Abhi Bhagat, Valentina Gallinaro, Giuliana Gualberti, Rocco Cosimo Damiano Merolla, Antonio Gasbarrini
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0280165 (2023)
IntroductionGlecaprevir/pibrentasvir (G/P) has demonstrated high rates (>95%) of sustained virologic response at posttreatment Week 12 (SVR12) in treatment-naïve (TN) patients with hepatitis C virus (HCV) infection and compensated cirrhosis (CC). He
Externí odkaz:
https://doaj.org/article/be07dcb5e1924a0cab48cd044e7a2346
Autor:
Luca Valenti, Armando Tripodi, Vincenzo La Mura, Serena Pelusi, Cristiana Bianco, Erica Scalambrino, Sara Margarita, Francesco Malvestiti, Luisa Ronzoni, Marigrazia Clerici, Roberta D’Ambrosio, Mirella Fraquelli, Rossana Carpani, Daniele Prati, Flora Peyvandi
Publikováno v:
JHEP Reports, Vol 4, Iss 12, Pp 100598- (2022)
Background & Aims: The aim of this study was to examine the determinants of the interplay between liver damage and the coagulation balance in individuals at risk of non-alcoholic fatty liver disease (NAFLD). Methods: We considered 581 healthy partici
Externí odkaz:
https://doaj.org/article/b046f8d74d0441cfa9d42ff22e969629
Autor:
Roberta D’Ambrosio, George N. Ioannou
Publikováno v:
Hepatology Communications, Vol 5, Iss 9, Pp 1465-1468 (2021)
Externí odkaz:
https://doaj.org/article/baed31704e824b7a9f941bbfac4e2bd5
Autor:
Roberta D'Ambrosio, Irene Campi, Marco Maggioni, Riccardo Perbellini, Enza Giammona, Roberta Stucchi, Marta Borghi, Elisabetta Degasperi, Annalisa De Silvestri, Luca Persani, Laura Fugazzola, Pietro Lampertico
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249614 (2021)
BackgroundData on the role of hypothyroidism in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis are conflicting, although selective Thyroid Hormone Receptor (THR)-β agonists have been identified as potential therapy
Externí odkaz:
https://doaj.org/article/d2e0fbea9990438f8cabd83bde15264b
Autor:
Roberta D’Ambrosio, Giuliano Rizzardini, Massimo Puoti, Stefano Fagiuoli, Maria Paola Anolli, Claudia Gabiati, Federico D’Amico, Luisa Pasulo, Umberto Restelli, Massimo Colombo, Pietro Lampertico
Publikováno v:
Liver International. 42:1012-1016
Background and Aim: The World Health Organization (WHO) goal of hepatitis C virus (HCV) elimination by 2030 relies on the scaling-up of both identification and linkage to care of the infected population, worldwide. In Italy, the estimated burden of H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ea1c1fdb41e9fd7ae49c2afe49a009
https://doi.org/10.1111/liv.15216
https://doi.org/10.1111/liv.15216
Autor:
Loreta A. Kondili, Maria Giovanna Quaranta, Luisa Cavalletto, Vincenza Calvaruso, Luigina Ferrigno, Roberta D'Ambrosio, Ilaria Simonelli, Giuseppina Brancaccio, Giovanni Raimondo, Maurizia R. Brunetto, Anna Linda Zignego, Carmine Coppola, Andrea Iannone, Elisa Biliotti, Gabriella Verucchi, Marco Massari, Anna Licata, Francesco Barbaro, Marcello Persico, Francesco Paolo Russo, Filomena Morisco, Maurizio Pompili, Mauro Viganò, Massimo Puoti, Teresa Santantonio, Erica Villa, Antonio Craxì, Liliana Chemello, Valentina Panetta, Giovanni Battista Gaeta, Roberto Filomia, Barbara Coco, Monica Monti, Daniela Caterina Amoruso, Salvatore Madonia, Donatella Ieluzzi, Gloria Taliani, Lorenzo Badia, Guglielmo Marco Migliorino, Alessia Giorgini, Mario Masarone, Pierluigi Blanc, Valentina Cossiga, Martina De Siena, Xhimi Tata, Maria Grazia Rumi, Luchino Chessa, Pietro Lampertico, Carlo Ferrari, Ivan Gentile, Giustino Parruti, Leonardo Baiocchi, Alessia Ciancio, Pietro Invernizzi, Alessandro Federico, Carlo Torti, Giulia Morsica, Pietro Andreone, Alessio Aghemo, Patrizia Popoli, Stefano Vella
Background and aims: Severe liver disease markers assessed before HCV eradication are acknowledged to usually improve after the SVR. We prospectively evaluated, in the PITER cohort, the long-term HCC risk profile based on predictors monitored after H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438d10f671907a94a75ee1d3ee7309a9
https://hdl.handle.net/2108/319297
https://hdl.handle.net/2108/319297
